HDAC5 and cardiac hypertrophy: Specially, a study demonstrates that sodium butyrate may function to inhibit HDAC5/HDAC6 to attenuate angiotensin (Ang) II-induced cardiac hypertrophy [7], suggesting HDAC5 may be a therapeutic target of cardiac hypertrophy.